Thumbnail Image
Publication

Compensation for trial-related injury

Ramanathan, Mala
; 
Sankara Sarma, P
; 
Mishra, Udaya S
Author(s)
Ramanathan, Mala
Sankara Sarma, P
Mishra, Udaya S
Contributor(s)
Keywords
Medical, Ethics, Grow
GE Subjects
Bioethics
Medical ethics
Health ethics
Collections
Health Ethics
Show all metadata
Files
Thumbnail Image
n204ar232.html.pdf
Adobe PDF, 341.03 KB
Research Projects
Organizational Units
Journal Issue
URI
http://hdl.handle.net/20.500.12424/190827
Online Access
Abstract
India’s regulatory framework for research ethics is two pronged. Schedule Y of the Drugs and Cosmetics Act, 1940, of the Government of India (1), lays down the requirements for undertaking clinical trials for drugs and medical devices in India; it also requires compliance with the ICMR’s Ethical guidelines for biomedical research on human participants (2) for such trials. Other health research may use the ICMR’s guidelines but this is not mandatory. The regulatory framework is operationalised through the offices of the Central Drugs Standard Control Organisation. However, the mechanisms of monitoring drug trials using this framework have proved to be rather weak.
Note(s)
Topic
Type
Article
Date
2012
Identifier
ISBN
DOI
Copyright/License
With permission of the license/copyright holder
Embedded videos